Intravitreal bevacizumab (Avastin) for the treatment of choroidal neovascularization in age-related macular degeneration: results from 118 cases. [electronic resource]
Producer: 20071206Description: 1716-7 p. digitalISSN:- 1468-2079
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Choroidal Neovascularization -- complications
- Female
- Follow-Up Studies
- Humans
- Injections
- Macula Lutea
- Macular Degeneration -- complications
- Male
- Middle Aged
- Retrospective Studies
- Tomography, Optical Coherence
- Visual Acuity
- Vitreous Body
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.